Legis Daily

Foreign Adversary Gain-of-Function Research Prevention Act of 2023

USA118th CongressHR-4087| House 
| Updated: 6/16/2023
Brad R. Wenstrup

Brad R. Wenstrup

Republican Representative

Ohio

Cosponsors (2)
Ronny Jackson (Republican)Debbie Lesko (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Foreign Adversary Gain-of-Function Research Prevention Act of 2023 This bill prohibits the use of federal funds by foreign adversaries for gain-of-function research involving pathogens that could cause a pandemic. ( Gain-of-function research is defined as research that enhances the pathogenicity or transmissibility of a pathogen in mammals.) Specifically, the bill prohibits federal funds from being used to support gain-of-function research involving potential pandemic pathogens by China, Russia, Iran, North Korea, or any other designated foreign adversary. Entities that violate the bill's requirements may not receive any funds from the Department of Health and Human Services (HHS) for three years and, for the following three years, may not receive any additional HHS funds unless they agree to give advance notice about how they intend to use the funds.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 117-4071
Foreign Gain-of-Function Research Prevention Act of 2021
Jun 13, 2023
Introduced in House
Jun 13, 2023
Referred to the House Committee on Energy and Commerce.
Jun 16, 2023
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-4071
    Foreign Gain-of-Function Research Prevention Act of 2021


  • June 13, 2023
    Introduced in House


  • June 13, 2023
    Referred to the House Committee on Energy and Commerce.


  • June 16, 2023
    Referred to the Subcommittee on Health.

Health

AsiaChinaEuropeForeign aid and international reliefInfectious and parasitic diseasesIranMedical researchMiddle EastNorth KoreaResearch administration and fundingRussia

Foreign Adversary Gain-of-Function Research Prevention Act of 2023

USA118th CongressHR-4087| House 
| Updated: 6/16/2023
Foreign Adversary Gain-of-Function Research Prevention Act of 2023 This bill prohibits the use of federal funds by foreign adversaries for gain-of-function research involving pathogens that could cause a pandemic. ( Gain-of-function research is defined as research that enhances the pathogenicity or transmissibility of a pathogen in mammals.) Specifically, the bill prohibits federal funds from being used to support gain-of-function research involving potential pandemic pathogens by China, Russia, Iran, North Korea, or any other designated foreign adversary. Entities that violate the bill's requirements may not receive any funds from the Department of Health and Human Services (HHS) for three years and, for the following three years, may not receive any additional HHS funds unless they agree to give advance notice about how they intend to use the funds.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 117-4071
Foreign Gain-of-Function Research Prevention Act of 2021
Jun 13, 2023
Introduced in House
Jun 13, 2023
Referred to the House Committee on Energy and Commerce.
Jun 16, 2023
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-4071
    Foreign Gain-of-Function Research Prevention Act of 2021


  • June 13, 2023
    Introduced in House


  • June 13, 2023
    Referred to the House Committee on Energy and Commerce.


  • June 16, 2023
    Referred to the Subcommittee on Health.
Brad R. Wenstrup

Brad R. Wenstrup

Republican Representative

Ohio

Cosponsors (2)
Ronny Jackson (Republican)Debbie Lesko (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AsiaChinaEuropeForeign aid and international reliefInfectious and parasitic diseasesIranMedical researchMiddle EastNorth KoreaResearch administration and fundingRussia